phosphotyrosine has been researched along with 6-ketoprostaglandin f1 alpha in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boarder, MR; Bowden, A; Brown, CA; Patel, V | 1 |
| Balabanova, L; Leffler, CW; Parfenova, H | 1 |
2 other study(ies) available for phosphotyrosine and 6-ketoprostaglandin f1 alpha
| Article | Year |
|---|---|
Stimulation of prostacyclin release by endothelial ATP receptors requires activation of protein kinase C and tyrosine kinases.
Topics: 6-Ketoprostaglandin F1 alpha; Adenosine Triphosphate; Animals; Aorta; Blotting, Western; Cattle; Cells, Cultured; Endothelium, Vascular; Enzyme Activation; Enzyme Inhibitors; Epoprostenol; Phosphotyrosine; Protein Kinase C; Protein-Tyrosine Kinases; Purinergic P2 Receptor Agonists; Receptors, Purinergic P2; Thionucleotides; Uridine Triphosphate | 1996 |
Posttranslational regulation of cyclooxygenase by tyrosine phosphorylation in cerebral endothelial cells.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Animals, Newborn; Aorta; Cells, Cultured; Cerebral Cortex; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Endothelium, Vascular; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Humans; Isoenzymes; Membrane Proteins; Microcirculation; Muscle, Smooth, Vascular; Nitriles; Nitrobenzenes; Phenols; Phosphoproteins; Phosphorylation; Phosphotyrosine; Prostaglandin-Endoperoxide Synthases; Protein Processing, Post-Translational; Protein-Tyrosine Kinases; Sulfonamides; Swine; Tyrphostins; Vanadates | 1998 |